Back

Meta-SAIGE: Scalable and Accurate Meta-Analysis for Rare Variants

Park, E.; Nam, K.; Jeong, S.; Keat, K.; Kim, D.; Bansal, V.; Zhou, W.; Lee, S.

2024-09-19 genetic and genomic medicine
10.1101/2024.09.17.24313855 medRxiv
Show abstract

A meta-analysis is a practical approach to increasing the power of rare variant tests by combining summary statistics from multiple cohorts. However, existing methods for rare variant meta-analysis often fail to correctly control type I error rates when analyzing low-prevalence binary traits and are computationally intensive when analyzing many phenotypes. This paper introduces Meta-SAIGE, a novel approach for rare variant meta-analyses that addresses these challenges. Meta-SAIGE reduces type I error inflation through precise estimation of the distribution of test statistics and allows the reuse of the linkage disequilibrium (LD) matrix across phenotypes, significantly improving computational efficiency for phenome-wide analyses. Simulation studies using UK Biobank whole-exome sequencing (WES) genotypes demonstrate that Meta-SAIGE effectively controls type I error rates and yields power similar to that of pooled individual-level data through SAIGE-GENE+. A meta-analysis of UK Biobank and All of Us WES data for 83 low prevalence disease phenotypes identified 237 associations. Notably, 80 of these associations were not significant in either dataset alone, underscoring the power of our meta-analysis.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.